Reach Us +1-218-451-2974


Kathleen C Campbell | OMICS International
ISSN: 2161-119X

Otolaryngology: Open Access
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

7th European Otolaryngology-ENT Surgery Conference

Vienna, Austria
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
Share This Page

Kathleen C Campbell

Southern Illinois University School of Medicine,Springfield


Dr. Campbell’s research focuses on bench to bedside translational research in the discovery and development of pharmacologic protective agents to prevent or reduce noise-induced hearing loss, aminoglycoside-induced ototoxicity and nephrotoxicity, cisplatin-induced ototoxicity, neurotoxicity, gastrointestinal toxicity, and alopecia, and radiation-induced oral mucositis. She has 6 US patents issued with foreign coverage.

She has an actively funded basic science research lab and funded clinical trials program with grants from National Institutes of Health, the Department of Defense and other agencies. Her research has generated over 8.2 million in national and international grants, contracts and patent income.

She is the author of Essential Audiology for Physicians and author/editor of Pharmacology and Ototoxicity for Audiologists which is a required text in most audiology doctoral programs.

Research Interest

Ototoxicity, otoprotective agents, anti-oxidants, drug development, clinical trials, Otolaryngology, Head and Neck Surgery.